Robert Doubleday is the Executive Director of the Centre for Science and Policy at the University of Cambridge. He was a Visiting Fellow with the Program on Science, Technology and Society (STS) at the Harvard Kennedy School of Government in 2001-2002.He works at the intersection of science and technology studies with geography, and focuses on the politics of science and emerging technologies. Doubleday is the principle investigator on a three-year Wellcome Trust funded project that studies the public dimensions of nano-biotechnology. The project involves policy analysis, laboratory studies and the development of novel collaborative methods, working with scientists to elaborate the public issues raised by their research.

Doubleday also leads a work package on the social and ethical aspects of nanotechnology as part of Frontiers, an EU FP6 Network of Excellence in nanotechnology. And he is a core member of the Nanotechnology Engagement Group, a UK Office of Science and Innovation funded project advising on policy lessons from public engagement with nanotechnology.

Robert Doubleday spent one year at the Kennedy School of Government on a Fulbright scholarship studying STS as part of the Reframing Rights project (2000-2001). He has a PhD in Geography (London, 2005), an MSc in Science Policy (Sussex, 1999) and a BSc in Chemistry (London, 1997).

Publications

Doubleday, R. (forthcoming) ‘Risk, Public Engagement and Reflexivity: how nanotechnology frames public deliberation’ (submitted for a special issue of Health, Risk & Society).

Doubleday, R. (forthcoming) ‘Organising Accountability: co-production of technoscientific and social worlds in a nanoscience laboratory’ (submitted for special section of Area)

Doubleday, R. and Lezaun, J. (2006) ‘Regulatory Measures: the incipient government of nanotechnology’ Risk and Regulation, 10: 6-7.

Doubleday, R. (2004) ‘Institutionalising NGO Dialogue at Unilever: framing the public as “consumer-citizens”‘ Science and Public Policy, 31: 117-126.

Doubleday, R. (2001) ‘Knowledge and the Governance of Biotechnology’ Notizie di Politeia, 17: 22-33.